SCIENMAG: Medicine & Health
AUGUST 14, 2023
Denny,” a 90,000-year-old fossil individual, recently identified as the daughter of a Denisovan father and a Neanderthal mother, bears testimony to the possibility that interbreeding was quite common among early human species. Contemporary humans carry in their cells a small amount of DNA derived from Neanderthals and Denisovans.
Translation
MAY 28, 2022
We hear recurring pain points among R&D leaders: Companies lack a systematic way to discover researchers and technologies outside of their geography, industry and existing relationships. In two months, Halo connected Oldcastle with sixty interested researchers. We had one researcher in mind.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog: Biosimilars
MARCH 29, 2024
That report prompted a hearing on Capitol Hill in February of this year where HPM Counsel John Claud offered testimony. According to GAO, FDA is facing challenges with clinical research inspections to ensure that the sites that oversee the research that lead to drug approvals meet the necessary standards.
The Pharma Data
OCTOBER 15, 2020
Researchers tracking a Reddit forum on CBD found many folks discussing use of cannabidiol to treat conditions for which there are proven, safe and effective medicines and therapies. Michael Bostwick, a psychiatrist and researcher at the Mayo Clinic in Rochester, Minn., THURSDAY, Oct. 15 in JAMA Network Open. 15 in JAMA Network Open.
PPD
JULY 6, 2023
It’s estimated that nearly three out of every four clinical trials are conducted by contract research organizations (CROs), highlighting just how much sponsors value — and rely on — the work that CROs perform. Surveys show that CROs improve trial efficiency and increase productivity.
Perficient: Drug Development
OCTOBER 8, 2024
Through our research, we determined that 75% of job seekers consider testimonials crucial when assessing potential employers, and 41% actively research hospital rankings online. Armed with this data, our team was able to create a compelling narrative that resonated with potential applicants.
Agency IQ
MARCH 25, 2024
The testimony of witnesses and the Senators themselves largely agreed on the designation, but diverged on questions of liability exemptions. The roadmap set timelines for the agency to develop new policies, protect the environment, and research the impacts of PFAS. The hearing also featured questions from BEN CARDIN (D-Md.),
Expert insights. Personalized for you.
84 
Let's personalize your content